(Q54278437)

27 May 2018

title

Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand. (English)

1 reference

27 May 2018

0 references

1 reference

Troels R Petersen

1

0 references

Dianne Sika-Paotonu

object named as

Dianne Sika-Paotonu

2

0 references

Ian F Hermans

object named as

Ian F Hermans

7

0 references

Franca Ronchese

6

object named as

Franca Ronchese

1 reference

27 May 2018

author name string

Deborah A Knight

3

1 reference

27 May 2018

Nina Dickgreber

4

1 reference

27 May 2018

Kathryn J Farrand

5

1 reference

27 May 2018

publication date

9 February 2010

1 reference

27 May 2018

Immunology & Cell Biology

published in

1 reference

27 May 2018

volume

88

1 reference

27 May 2018

issue

5

1 reference

27 May 2018

page(s)

596-604

1 reference

27 May 2018

cites work

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Interleukin-12 in anti-tumor immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

CD4+CD25+ Tregs and NKT cells: regulators regulating regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Immune regulation in tumor-bearing hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Antigens for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Glycolipid antigen induces long-term natural killer T cell anergy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Activation or anergy: NKT cells are stunned by alpha-galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Electroporation in ‘intracellular’ buffer increases cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.9

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.9

1 reference

27 May 2018

1 reference

27 May 2018